Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Annemarie Le Roux.

“I love working with children.” This is one of the first things Annemarie le Roux mentions when asked to describe herself. This love for children propelled Annemarie into the field of education and she graduated in 2006 with a BEd in Foundation Phase at the UFS. Annemarie immediately immersed herself in the Deaf community, enriching the lives of children at the Thiboloha School for the Deaf in Qwaqwa and the De la Bat School for the Deaf in Worcester. 

The academic world enticed Annemarie back to the University of the Free State (UFS) and she was appointed as a junior lecturer in the Department of South African Sign Language (SASL) and Deaf Studies in 2013. Going from strength to strength, Annemarie completed her master’s degree in SASL in 2019, and published an article earlier this year that she co-wrote with Marga Stander. In this article, they found that SASL “has become an increasingly popular language that hearing university students want to learn as a second language” and subsequently explored different teaching methods used for this emerging group of interested students. 

Although now firmly established in academia, Annemarie is still committed to the practical application of SASL. “I am closely involved in student and community engagement through the SIGNALS Sign Language student association that helps empower the Deaf community and South African Sign Language.” She also interprets for the Deaf community whenever she gets an opportunity, as well as for Deaf students in class and meetings.

On the importance of Sign Language and the recognition of the Deaf community in South Africa, Annemarie believes it will open greater opportunities for development. “More people will be able to learn SASL, and it might even become a subject in school for hearing children.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept